Cargando…
The Discovery of New Drug-Target Interactions for Breast Cancer Treatment
Drug–target interaction (DTIs) prediction plays a vital role in probing new targets for breast cancer research. Considering the multifaceted challenges associated with experimental methods identifying DTIs, the in silico prediction of such interactions merits exploration. In this study, we develop a...
Autores principales: | Song, Jiali, Xu, Zhenyi, Cao, Lei, Wang, Meng, Hou, Yan, Li, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704452/ https://www.ncbi.nlm.nih.gov/pubmed/34946556 http://dx.doi.org/10.3390/molecules26247474 |
Ejemplares similares
-
Improving ovarian cancer treatment decision using a novel risk predictive tool
por: Xu, Zhenyi, et al.
Publicado: (2022) -
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022) -
Targeting protein-protein interaction interfaces in COVID-19 drug discovery
por: Chang, Chung-ke, et al.
Publicado: (2021) -
Functional genomics for breast cancer drug target discovery
por: Yoshimaru, Tetsuro, et al.
Publicado: (2021) -
Drug discovery by targeting the protein–protein interactions involved in autophagy
por: Xiang, Honggang, et al.
Publicado: (2023)